Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

In silico–guided Design and Endonuclease-Based Functional Validation of sgRNAs Targeting ERBB2 Transmembrane and Kinase Domains

The Indonesian Biomedical Journal · Vol. 18 No. 2 (2026) · hlm. 164–172

DOI
10.18585/inabj.v18i2.4048
ISSN
2085-3297, 2355-9179
Terbit
2026-04-29
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Erythroblastic oncogene B2 (ERBB2) overexpression promotes breast cancer progression through activation of phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways. Although CRISPR–Cas9 enables precise gene disruption, sgRNA efficiency is strongly influenced by target sequence and structural features, necessitating careful in silico design and validation. This study aimed to design and evaluate sgRNAs targeting the transmembrane- and tyrosine kinase–encoding regions of ERBB2.METHODS: Candidate sgRNAs were selected using CHOPCHOP, CRISPOR, and CRISPR RGEN, followed by secondary structure analysis with RNAfold to assess folding stability and scaffold integrity. sgRNAs were synthesized via in vitro transcription and assembled with Cas9 protein to form ribonucleoprotein (RNP) complexes. In vitro endonuclease assays were performed using PCR-amplified ERBB2 fragments derived from SK-OV3 genomic DNA, corresponding to exon 22 (523 bp) and exon 25 (933 bp). sgRNAs targeting eIF4E1 served as positive controls.RESULTS: Two sgRNAs meeting all in silico criteria were selected. Secondary structure prediction confirmed that both sgRNAs possessed essential structural elements required for Cas9 interaction including the repeat–anti-repeat region and three stem–loop structures. In vitro endonuclease assays demonstrated that the sgRNA targeting exon 22 of ERBB2 successfully cleaved its target DNA, producing fragments of 266 bp and 257 bp. Similar cleavage activity was observed in the two control sgRNAs, which generated fragments of 384 bp and 303 bp, and 486 bp and 201 bp, respectively. In contrast, the sgRNA targeting exon 25 of ERBB2 exhibited no detectable cleavage activity.CONCLUSION: The sgRNA targeting exon 22 of ERBB2 demonstrated effective DNA cleavage activity in vitro, whereas the sgRNA targeting exon 25 showed no endonuclease activity.KEYWORDS: CRISPR–Cas9, endonuclease, ERBB2, in vitro, breast cancer, RNP, sgRNA

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 131 tautan kepenulisan bersama · 34 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Bandung Institute of Technology
  • Indonesia University of Education
  • Udayana University
  • Andalas University
  • Tokyo Institute of Technology
  • Universidad de la República de Uruguay
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Fenny Martha DwivanyBandung Institute of Technology5
Ernawati Arifin Giri-RachmanBandung Institute of Technology4
Agus SutantoAndalas University2
Dessy NataliaBandung Institute of Technology2
Anita ArtariniBandung Institute of Technology2
Topik HidayatIndonesia University of Education1
Himalaya Wana KelanaIndonesia University of Education1
Dhiyassalam Imam Anshori IsmantoIndonesia University of Education1
I NyomanUdayana University1
I Made SukewijayaUdayana University1
I Nyoman Gede UstriyanaUdayana University1
AnindyajatiAfiliasi tidak diketahui1
Catur RianiBandung Institute of Technology1
Ernawati Arifin Giri-RachmanBandung Institute of Technology1
Salma Aulia AfifahBandung Institute of Technology1
DEBBIE SOEFIE RETNONINGRUMBandung Institute of Technology1
Rukman HertadiBandung Institute of Technology1
Novia Syari IntanBandung Institute of Technology1
Putri Ayu FajarBandung Institute of Technology1
Gladys Emmanuella Putri WojciechowskaBandung Institute of Technology1
Intan FatmawatiBandung Institute of Technology1
Ketut WikantikaBandung Institute of Technology1
Husna NugrahaprajaBandung Institute of Technology1
Sigit Nur PratamaBandung Institute of Technology1
Rizkita Rachmi EsyantiBandung Institute of Technology1
Muhammad Abdul AzizBandung Institute of Technology1
Hany Husnul ChotimahBandung Institute of Technology1
Erdianty SetiabudiBandung Institute of Technology1
Intan TaufikBandung Institute of Technology1
Josefanny ThamBandung Institute of Technology1
Alfred PatisenahBandung Institute of Technology1
Tommy Octavianus Soetrisno TjiaTokyo Institute of Technology1
Santiago SignorelliUniversidad de la República de Uruguay1
Irham HayatiBandung Institute of Technology1
Anggraini BarlianBandung Institute of Technology1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">In silico–guided Design and Endonuclease-Based Functional Validation of sgRNAs Targeting ERBB2 Transmembrane and Kinase Domains</dc:title><dc:creator>Via Susana Gunsi</dc:creator><dc:creator>Anugrah Prima Dirgahyu</dc:creator><dc:creator>Karlia Meitha</dc:creator><dc:creator>Antonius Christianto</dc:creator><dc:creator>Marselina Irasonia Tan</dc:creator><dc:subject>ERBB2</dc:subject><dc:subject>HER2</dc:subject><dc:subject>CRISPR/Cas9</dc:subject><dc:subject>guide RNA design</dc:subject><dc:subject>single guide RNA</dc:subject><dc:subject>transmembrane domain</dc:subject><dc:subject>tyrosine kinase domain</dc:subject><dc:subject>in silico design</dc:subject><dc:subject>secondary structure prediction</dc:subject><dc:subject>endonuclease activity</dc:subject><dc:subject>ribonucleoprotein</dc:subject><dc:subject>breast cancer</dc:subject><dc:subject>PI3K/Akt signaling</dc:subject><dc:subject>MAPK signaling</dc:subject><dc:description xml:lang="en">BACKGROUND: Erythroblastic oncogene B2 (ERBB2) overexpression promotes breast cancer progression through activation of phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways. Although CRISPR–Cas9 enables precise gene disruption, sgRNA efficiency is strongly influenced by target sequence and structural features, necessitating careful in silico design and validation. This study aimed to design and evaluate sgRNAs targeting the transmembrane- and tyrosine kinase–encoding regions of ERBB2.METHODS: Candidate sgRNAs were selected using CHOPCHOP, CRISPOR, and CRISPR RGEN, followed by secondary structure analysis with RNAfold to assess folding stability and scaffold integrity. sgRNAs were synthesized via in vitro transcription and assembled with Cas9 protein to form ribonucleoprotein (RNP) complexes. In vitro endonuclease assays were performed using PCR-amplified ERBB2 fragments derived from SK-OV3 genomic DNA, corresponding to exon 22 (523 bp) and exon 25 (933 bp). sgRNAs targeting eIF4E1 served as positive controls.RESULTS: Two sgRNAs meeting all in silico criteria were selected. Secondary structure prediction confirmed that both sgRNAs possessed essential structural elements required for Cas9 interaction including the repeat–anti-repeat region and three stem–loop structures. In vitro endonuclease assays demonstrated that the sgRNA targeting exon 22 of ERBB2 successfully cleaved its target DNA, producing fragments of 266 bp and 257 bp. Similar cleavage activity was observed in the two control sgRNAs, which generated fragments of 384 bp and 303 bp, and 486 bp and 201 bp, respectively. In contrast, the sgRNA targeting exon 25 of ERBB2 exhibited no detectable cleavage activity.CONCLUSION: The sgRNA targeting exon 22 of ERBB2 demonstrated effective DNA cleavage activity in vitro, whereas the sgRNA targeting exon 25 showed no endonuclease activity.KEYWORDS: CRISPR–Cas9, endonuclease, ERBB2, in vitro, breast cancer, RNP, sgRNA</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2026-04-29</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v18i2.4048</dc:identifier><dc:identifier>10.18585/inabj.v18i2.4048</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 18 No 2 (2026); 164-172</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/4048/836</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>